Autoimmune markers in lymphoid malignancies

Scandinavian Journal of Immunology

Volumn 67, Issue 5, 2008, Pages 509-515

  Sjoberg K ^a,b   Roth, E B ^c   Gustavsson, L ^b   Jonsson C ^b   Siman H ^d   Henriksson, G ^b   Stenberg, P ^c   Lindblom, A ^b   Svensson, P ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Hospital Pharmacy   (Sweden)

^d CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; CELL NUCLEUS ANTIGEN; IMMUNOGLOBULIN G; PREDNISONE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIG; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, NUCLEAR; AUTOANTIBODIES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XIII; FEMALE; GUINEA PIGS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; TRANSGLUTAMINASES;

EID: 42049094493     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02095.x     Document Type: Article

References (49)

1. Hennessy BT, Hanrahan EO, Daly PA. Non-Hodgkin lymphoma: an update. Lancet Oncol 2004 5 : 341 53.
2. Evans LS, Hancock HW. Non-Hodgkin lymphoma. Lancet 2003 362 : 139 46.
3. Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis 2001 27 : 750 6.
4. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Engl J Med 2004 350 : 213 5.
5. Swinson CM, Slavin G, Coles EC, Booth CC. Coeliac disease and malignancy. Lancet 1983 1 : 111 5.
6. Catassi C, Fabiani E, Corrao G et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002 287 : 1413 9.
7. Green PHR, Fleischauer AT, Bhagat G et al. Risk of malignancy in patients with celiac disease. Am J Med 2003 115 : 191 5.
8. Smedby KE, Åkerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005 54 : 54 9.
9. Cooper BT, Holmes GK, Cooke WT. Lymphoma risk in coeliac disease of later life. Digestion 1982 23 : 89 92.
10. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004 20 : 769 75.
11. Anderson LA, McMillan SA, Watson RG et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity". World J Gastroenterol 2007 13 : 146 51.
12. Silano M, Volta U, Mecchia AM et al. Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 2007 7 : 8.
13. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease-effect of a gluten free diet. Gut 1989 30 : 333 8.
14. Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006 38 : 374 80. Epub 2006 Apr 14.
15. Silano M, Volta U, Vincenzi AD, Dessi M, Vincenzi MD. The Collaboratoring Centers of the Italian Registry of the complications of coeliac disease. Effect of a Gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci 2007 13 [Epub ahead of print].
16. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997 3 : 797 801.
17. Sardy M, Karpati S, Merkl B et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002 195 : 747 57.
18. Sjöberg K, Eriksson S, Tenngart B et al. Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease. Autoimmunity 2002 35 : 357 64.
19. Kassan SS, Thomas TL, Moutsopoulos HM et al. Increased risk of lymphoma in Sicca syndrome. Ann Intern Med 1978 89 : 888 92.
20. Theander E, Henrikssson G, Ljungberg O et al. Lymphoma and other malignancies in primary Sjogren′s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006 65 : 704 6.
21. Kauppi M, Pukkala E, Isomaki H. Elevated incidence of hematologic malignancies in patients with Sjogren′s syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997 8 : 201 4.
22. Soliotis FC, Moutsopoulos HM. Sjogren's syndrome. Autoimmunity 2004 37 : 305 7.
23. Reichlin M, Scofield RH. SS-A (Ro) autoantibodies. In : Peter JB, Shoenfeld Y, eds. Autoantibodies. Amsterdam : Elsevier, 1996 : 783 8.
24. Keech CL, McCluskey J, Gordon TP. SS-B (La) autoantibodies. In : Peter JB, Shoenfeld Y, eds. Autoantibodies. Amsterdam : Elsevier, 1996 : 789 97.
25. Váróczy L, Gergely L, Zeher M et al. Malignant lymphoma-associated autoimmune diseases - a descriptive epidemiological Study. Rheumatol Int 2002 22 : 233 7.
26. Guyomard S, Salles G, Coudurier M et al. Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin lymphoma. Br J Haematol 2003 123 : 90 9.
27. Pusterla S, Previtali S, Marziali S et al. Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J 2004 5 : 341 6.
28. Roth EB, Stenberg P, Book C, Sjöberg K. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis - new pathways to epitope spreading. Clin Exp Rheumatol 2006 24 : 12 8.
29. Palli D, Masala G, Guidice GD et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EUROGAST study. Int J Cancer 2006 120 : 859 67.
30. Gnarpe H, Unge P, Blomqvist C, Makitalo S. Campylobacter pylori in Swedish patients referred for gastroscopy. APMIS 1988 96 : 128 32.
31. Eck M, Schmausser B, Kerkau T et al. Autoantibodies in gastric MALT-type lymphoma. Ann Oncol 2003 14 : 1153 6.
32. Mäki M. Tissue transglutaminase as the autoantigen of coelaic disease. Gut 1997 41 : 565 6.
33. Carroccio A, Iannitto E, Di Prima L et al. Screening for celiac disease in Non-Hodgkin lymphoma patients. A serum anti-transglutaminase-based approach. Dig Dis Sci 2003 48 : 1530 6.
34. Carroccio A, Giannitrapani L, Soresi M et al. Guine pig transglutaminase immunolinked assay does not predict coeliac disease in patients with liver disease. Gut 2001 49 : 506 11.
35. Kiss F, Hevessy Z, Veszpremi A et al. Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A. Thromb Haemost 2006 96 : 176 82.
36. Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 2005 38 : 55 63.
37. Boire G, Lopez-Longo FJ, Lapointe S, Menard HA. Sera from patients with autoimmune disease recognize conformational determinants of the 60-kd Ro/SSA protein. Arthritis Rheum 1991 34 : 722 30.
38. Bergey B, Marchildon P, Peacock J, Megraud F. What is the role of serology in assessing Helicobacter pylori eradication? Aliment Pharmacol Ther 2003 18 : 635 9.
39. Picarelli A, DiTola M, Sabbatella L et al. Anti tissue transglutaminase antibodies in arthritic patients: a disease-specific finding? Clin Chem 2003 49 : 2091 4.
40. Barcellini W, Capalbo S, Agostinelli RM et al. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. Haematologica 2006 91 : 1689 92.
41. Hamblin TJ. Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 2006 33 : 230 9.
42. Pritsch O, Maloum K, Dighiero G. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia. Semin Oncol 1998 25 : 34 41.
43. Ward JH. Autoimmunity in chronic lymphocytic leukemia. Curr Treat Options Oncol 2001 2 : 253 7.
44. Jønsson V, Wiik A, Hou-Jensen K et al. Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. J Intern Med 1999 245 : 277 86.
45. Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 1999 17 : 399 408.
46. Cuttner J, Spiera H, Troy K, Wallenstein S. Autoimmune disease is a risk factor for the development of Non-Hodgkin lymphoma. J Rheumatol 2005 32 : 1884 7.
47. Kourtis AP, Boussiotis VA, Lymberi P, Pangalis GA. Increased natural antibodies activity in sera of patients with malignant non-Hodgkin lymphomas containing paraproteins. Am J Hematol 1994 46 : 283 8.
48. Barrios Y, Plaza A, Cabrera R, Diaz-Espada F. Autoantibody activity of the Immuno-globulin secreted by a follicular B-cell lymphoma. APMIS 2000 108 : 764 70.
49. Lehman PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992 358 : 155 7.